Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 7, 2013, Pages

  Mukherjee, Budhaditya ^a   Mukhopadhyay, Rupkatha ^a   Bannerjee, Bijoylaxmi ^a   Chowdhury, Sayan ^a   Mukherjee, Sandip ^a   Naskar, Kshudiram ^a   Allam, Uday Sankar ^b   Chakravortty, Dipshikha ^b   Sundar, Shyam ^c   Dujardin, Jean Claude ^d,e   Roy, Syamal ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c BANARAS HINDU UNIVERSITY   (India)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antimony efflux; Antimony resistance; Glycoconjugate; Visceral leishmaniasis

Indexed keywords

ANTIMONY; GLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MULTIDRUG RESISTANCE PROTEIN 1; N ACETYLGALACTOSAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT INTERLEUKIN 10; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; ENZYME THERAPY; LEISHMANIA DONOVANI; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIMONY; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; CRICETINAE; DNA PRIMERS; DRUG RESISTANCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; INTERLEUKIN-10; LEISHMANIA DONOVANI; MACROPHAGES; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 84873706806     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1213839110     Document Type: Article

References (48)

1. Desjeux P (2004) Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27(5):305-318.
2. Rabello A, Orsini M, Disch J (2003) Leishmania/HIV co-infection in Brazil: An appraisal. Ann Trop Med Parasitol 97(Suppl 1):17-28.
3. Brahmachari UN (1989) Chemotherapy of antimonial compounds in kala-azar infection. Part I. By U. N. Brahmachari, 1922. Indian J Med Res 89:492-522.
4. Lira R, et al. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180(2):564-567. (Pubitemid 30256350)
5. Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19(1):111-126. (Pubitemid 43157649)
6. Chakravarty J, Sundar S (2010) Drug resistance in leishmaniasis. J Glob Infect Dis 2(2):167-176.
7. Mukhopadhyay R, et al. (2011) Characterisation of antimony-resistant Leishmania donovani isolates: Biochemical and biophysical studies and interaction with host cells. Int J Parasitol 41(13-14):1311-1321.
8. Downing T, et al. (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 21(12):2143-2156.
9. Haldar AK, et al. (2010) Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Pathog 6(5):e1000907.
10. Mookerjee Basu J, et al. (2008) Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother 52(3):1080-1093.
11. Dobson DE, et al. (2003) Functional identi fi cation of galactosyltransferases (SCGs) required for species-specific modi fi cations of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactions. J Biol Chem 278(18):15523-15531. (Pubitemid 36799659)
12. Chandra D, Naik S (2008) Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin Exp Immunol 154(2):224-234.
13. Feng GJ, et al. (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163(12):6403-6412.
14. Martin M, et al. (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 171(2):717-725. (Pubitemid 36871381)
15. Saraiva M, et al. (2005) Identification of a macrophage-specific chromatin signature in the IL-10 locus. J Immunol 175(2):1041-1046. (Pubitemid 41094989)
16. Cao S, Zhang X, Edwards JP, Mosser DM (2006) NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281(36):26041-26050. (Pubitemid 44401810)
17. Lin CF, Chen CL, Lin YS (2006) Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem 13(14):1609-1616. (Pubitemid 43821694)
18. Misra S, Ghatak S, Toole BP (2005) Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 280(21):20310-20315. (Pubitemid 40776728)
19. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG (2003) Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32(4):364-371. (Pubitemid 36407536)
20. Hsu SI, et al. (1990) Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells. Mol Cell Biol 10(7):3596- 3606.
21. Mookerjee Basu J, et al. (2006) Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother 50(5):1788-1797.
22. de Veer MJ, et al. (2003) MyD88 is essential for clearance of Leishmania major: Possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 33(10):2822-2831. (Pubitemid 37337148)
23. Thakur CP, Mitra DK, Narayan S (2003) Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Trans R Soc Trop Med Hyg 97(4):409-412. (Pubitemid 39186020)
24. Verma S, et al. (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS ONE 5(4):e10107.
25. Vanaerschot M, et al. (2010) Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS ONE 5(8):e12211.
26. Vanaerschot M, et al. (2011) Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS ONE 6(8):e23120.
27. Kang YS, et al. (2004) The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci USA 101(1):215-220.
28. Turco SJ, Descoteaux A (1992) The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol 46:65-94.
29. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2(1):48-58. (Pubitemid 37328807)
30. Stassi G, et al. (2003) Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 63(20):6784-6790. (Pubitemid 37322959)
31. Loscher CE, et al. (2005) Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 175(8):4990-4998. (Pubitemid 41456381)
32. Contreras I, et al. (2010) Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog 6(10):e1001148.
33. Bhattacharyya S, Ghosh S, Jhonson PL, Bhattacharya SK, Majumdar S (2001) Immunomodulatory role of interleukin-10 in visceral leishmaniasis: Defective activation of protein kinase C-mediated signal transduction events. Infect Immun 69(3):1499- 1507.
34. Guizani-Tabbane L, Ben-Aissa K, Belghith M, Sassi A, Dellagi K (2004) Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: Involvement in cytokine synthesis. Infect Immun 72(5):2582-2589. (Pubitemid 38542384)
35. Asong J, Wolfert MA, Maiti KK, Miller D, Boons GJ (2009) Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria. J Biol Chem 284(13):8643-8653.
36. Srivastav S, Kar S, Chande AG, Mukhopadhyaya R, Das PK (2012) Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response. J Immunol 189(2):924-934.
37. Ozinsky A, et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97(25):13766-13771.
38. Chang S, Dolganiuc A, Szabo G (2007) Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol 82(3):479-487. (Pubitemid 47367138)
39. Park HJ, et al. (2011) IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Mol Immunol 48(4):720-727.
40. Pérez-Victoria JM, et al. (2011) Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania. Antimicrob Agents Chemother 55(8):3838-3844.
41. Sundar S, et al. (2012) Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 55(4):543-559.
42. Mukhopadhyay S, Sen P, Bhattacharyya S, Majumdar S, Roy S (1999) Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 17(3):291-300. (Pubitemid 28552790)
43. Hart DT, Vickerman K, Coombs GH (1981) A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 82(Pt 3):345-355. (Pubitemid 11084017)
44. Chakraborty D, et al. (2005) Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175(5):3214-3224. (Pubitemid 41170542)
45. Greig N, Wyllie S, Patterson S, Fairlamb AH (2009) A comparative study of methylglyoxal metabolism in trypanosomatids. FEBS J 276(2):376-386.
46. Kapler GM, Coburn CM, Beverley SM (1990) Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol 10(3):1084- 1094.
47. Kang DI, Kang HK, Gwak HS, Han HK, Lim SJ (2009) Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Drug Deliv 16(5):261-267.
48. Sen S, Roy K, Mukherjee S, Mukhopadhyay R, Roy S (2011) Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: Role of membrane cholesterol. PLoS Pathog 7(9):e1002229.